US restores $600 million in Gavi support amid vaccine policy shifts and thimerosal dispute

The United States has reinstated $600 million in funding for Gavi, reversing earlier withholding decisions, with conditions to phase out mercury-based thimerosal in vaccines and navigate ongoing legal and diplomatic challenges surrounding vaccine policies. The United States has restored $600…















